The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathway
Top Cited Papers
- 7 April 2005
- journal article
- research article
- Published by Elsevier
- Vol. 1044 (1) , 127-131
- https://doi.org/10.1016/j.brainres.2005.03.011
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cellsAutonomic Neuroscience, 2004
- Characterization of Blood-Brain Barrier Permeability to PYY3-36 in the MouseThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Gut hormone PYY3-36 physiologically inhibits food intakeNature, 2002
- The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasisInternational Journal of Obesity, 2001
- The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesityInternational Journal of Obesity, 2001
- Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese ratsMetabolism, 2000
- Two molecular forms of Peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1–36 and PYY 3–36Regulatory Peptides, 1994
- Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the ratNeuroscience, 1989
- Central connections of the sensory and motor nuclei of the vagus nerveJournal of the Autonomic Nervous System, 1983
- Abdominal Vagotomy Blocks the Satiety Effect of Cholecystokinin in the RatScience, 1981